Highline Capital Management’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-180,605	Closed	-$10.4M	–	36
2019 Q1	$10.4M	Sell	180,605 -378,007	-68%	-$21.7M	0.65%	30
2018 Q4	$23.4M	Buy	558,612 +216,612	+63%	+$9.09M	1.57%	20
2018 Q3	$25.8M	Sell	342,000 -8,000	-2%	-$604K	1.19%	22
2018 Q2	$25.1M	Buy	+350,000	New	+$25.1M	0.84%	28